Method for inhibiting degradation of brain natriuretic peptides

Details Method for inhibiting degradation of brain natriuretic peptides Method for inhibiting degradation of brain natriuretic peptides

2007-06-05

2007-06-05

Gitomer, Ralph (Department: 1655)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S069200

Reexamination Certificate

active

09530013

ABSTRACT:
A method for inhibiting the degradation of mammalian natriuretic peptides, in particular BNP, by using containers wherein the face coming into contact with specimens are made of silicone or plastics. This material inhibits the activation of a substance, which in turn, degrades the peptides. This method makes it possible to collect specimens for measuring natriuretic peptides stably and conveniently. Also provided is a method for measuring natriuretic peptides by using these containers.

REFERENCES:
patent: 4647455 (1987-03-01), DeBold
patent: 4663437 (1987-05-01), DeBold
patent: 5057495 (1991-10-01), Flynn et al.
patent: 0 393 640 (1990-10-01), None
patent: 0 401 006 (1990-12-01), None
patent: 0 709 678 (1996-05-01), None
patent: WO-93/24531 (1993-12-01), None
Lindberg B. Adsorption of ANP to Different Materials. Pharmacology & Toxicology 68(4)276-281 1991.
Clerico A. Analytical Performance and Clinical Usefulness of a Commercially Available IRMA Kit. Clinical Chem 42(10)1627-1633, 1996.
Nelesen R. et al. Plasma Atrial Natriuretic Peptide is Unstable Under Most Storage Conditions. Circulation vol. 86, pp. 463-466, 1992.
Davidson N. et al. N Terminal Proatrial Natriuretic Peptide and Brain Natriuretic Peptide are Stable for Up to 6 Hours in Whole Blood In Vitro. Circulation 91(4)1276, 1995.
Clin. Chem, vol. 42, No. 10, pp. 1627-1633 (1996).
Biochemical and Biophysical Research Communications, vol. 161, No. 3, pp. 1177-1183 (1989).
Pharmacology & Toxicology, vol. 68, No. 4, pp. 276-281 (1991).
P.J. Hunt et al., Biochem. Biophys. Res. Commun., 214(3) :1175-1183 (1995).
Nelesen et al.; Plasma Atrial Natriuretic Peptide is Unstable Under Most Storage Conditions; Circulation, vol. 86, No. 2; Aug. 1992; pp. 463-466.
Davidson et al.; Circulation, vol. 91, No. 4; Feb. 15, 1995; pp. 1276-1277.
Tsuji et al.; “Stability of human atrial natriuretic peptide in blood samples”; Clinica Chimica Acta, 225; 1994; pp. 171-177.
Omland et al.; “Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial Infarction”; Circulation, vol. 93, No. 11; Jun. 1, 1996; pp. 1963-1969.
Van der Kamp et al.; “Contact activation during incubation of five different polyurethanes or glass in plasma”; J. Biomed Mater, Res.; Oct. 1995; 1303-1306.
Ballermann; “A highly sensitive radioreceptor assay for atrial natriuretic peptide in rat plasma”; Am. J. Phys. 254:1; pp. F159-F163 1988.
Costar: Corning Microplate selection guide, published Nov. 30, 2005, pp. 3 and 6.
Greiner: current catalogue 2005/2006 section 2, HTS Microplates, pp. 2, 6, 10.

Affiliated with

Also associated with

Rating

Method for inhibiting degradation of brain natriuretic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for inhibiting degradation of brain natriuretic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting degradation of brain natriuretic peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3836165